Transaction Details

Footnotes

Sale was made pursuant to a Rule 10b5-1 Plan adopted by the Reporting Person on September 4, 2025. | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $100.485 to $101.45, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. | Total shares beneficially owned includes 29,800 shares of which the Reporting Person has elected to defer receipt pursuant to the Akamai Technologies, Inc. Amended and Restated U.S. Non-Qualified Deferred Compensation Plan. | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $101.52 to $101.99, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. | As of March 9, 2026.